Portfolio company
Concerto BioSciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops microbe-based ingredients and therapeutics for skincare and healthcare companies using a combinatorial screening platform to map microbial interactions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Symbiome
This company develops microbiome-based skincare products using Amazonian ingredients for consumers seeking to restore skin health and resilience.
Kanvas Biosciences
This company develops microbiome mapping platforms and live biotherapeutic products for pharmaceutical companies and research institutions focused on treating cancer and inflammatory diseases.
Arcaea
This company develops bioengineered ingredients and personal care products using DNA sequencing and fermentation for beauty brands and retail consumers.
KOBIOLABS
This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.
Outpost Bio
This company builds machine learning models of the human microbiome to help pharmaceutical and consumer health teams predict drug interactions and ingredient efficacy.
Debut Biotechnology
This synthetic biology company develops bioactive ingredients and skincare formulations for beauty manufacturers and direct-to-consumer markets using AI-driven discovery and cell-free biomanufacturing.
Biosyntia
This company develops vitamins and plant-based active ingredients via microbial fermentation for customers in the nutrition, food, and beauty sectors.
mbiomics
This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.
